ADHD in Japan: The Complete Guide for Foreign Residents
ADHD can be diagnosed and treated in Japan, health insurance covers it, and English-speaking care exists. But Japan handles ADHD medication more strictly than almost any other developed country, and this catches foreign residents off guard in three ways: Adderall is flatly illegal here, a diagnosis from abroad must be re-confirmed by a doctor in Japan before stimulants can be prescribed, and the main stimulant, Concerta, runs through a national registration system that has been under supply pressure.
None of these are dead ends. They just mean ADHD is the one area of psychiatric care where you should understand the system before you move, not after.
Can you continue ADHD treatment from abroad?
Yes, but not by handing over your old prescription. Foreign prescriptions have no force in Japan, and to prescribe a stimulant the doctor must confirm the ADHD diagnosis themselves under the registration system. A letter saying "diagnosed in 2019" helps enormously as evidence, but it doesn't substitute for the Japanese doctor's own assessment.
In practice: bring your records (diagnosis, test results, medication history with doses and response), book a psychiatrist who handles adult ADHD, and expect the first visits to revisit your history before medication is arranged. With good records this is much faster than a from-scratch diagnosis, and non-stimulant medication can typically start sooner. Full walkthrough in our step-by-step diagnosis guide.
Which ADHD medications are legal in Japan?
| Medication | Status in Japan |
|---|---|
| Adderall, Dexedrine (amphetamines) | Illegal. No prescribing pathway, and cannot be brought into the country in any amount |
| Concerta (methylphenidate ER) | Approved for all ages, but only via registered doctors, pharmacies, and patients |
| Ritalin (methylphenidate IR) | Available, but approved only for narcolepsy, not ADHD |
| Vyvanse (lisdexamfetamine) | Approved only for ages 6-18; cannot be started in adults |
| Strattera (atomoxetine) | Approved for all ages, ordinary prescription, generics available |
| Intuniv (guanfacine ER) | Approved for all ages, ordinary prescription |
Two consequences follow. If you take Adderall, do not bring it to Japan under any circumstances; possession is a criminal matter with no exemption paperwork, so plan a medication change before the move. And if you're an adult on Vyvanse, it can't be started in adults here; the usual path is Concerta or a non-stimulant. Travel rules differ by drug (Vyvanse needs advance permission; Concerta can be carried within a quantity allowance); see our guide to bringing ADHD medication into Japan and the ministry's English import pages.
What is the registration system?
A triple registration: your doctor, your pharmacy, and you. Since late 2019, Concerta and Vyvanse prescriptions run through a proper-distribution management system (ADHD適正流通管理システム), built to prevent stimulant diversion, which Japan treats with unusual seriousness for historical reasons. Three registrations line up: the doctor (documented ADHD training required), the pharmacy, and you, registered at your first prescription with photo ID and a patient card checked at each dispensing.
Practically: choose a clinic that is actually registered, bring photo identification, and expect a thorough diagnosis conversation rather than a five-minute formality. Once registered, ongoing prescriptions are routine. It is a pharmaceutical control, not a government watchlist; medical confidentiality applies as usual.
The Concerta supply shortage
The pressure built in stages: brand-name Strattera production stopped in late 2024 over an impurity issue, demand shifted to Concerta amid a sharp rise in adult diagnoses, and by late 2025 Concerta itself went into shortage, with new patient registrations restricted so existing patients could keep their treatment.
As of this writing in mid-2026: continuing patients have been protected throughout; new starts may face a waiting list or an alternative first. The alternatives are real options, not consolation prizes: generic atomoxetine (which stayed available) and guanfacine both treat ADHD effectively for many adults and sit outside the stimulant registration system. We keep a regularly updated article on the supply situation.
How does getting diagnosed in Japan work?
The typical path at a clinic that handles adult ADHD: a detailed interview about your current difficulties and your childhood (ADHD is developmental, so evidence of symptoms before roughly age 12 matters; school records and a parent's memories genuinely help), standardized rating scales, and sometimes optional cognitive testing such as the WAIS, which can clarify your profile but is not by itself an ADHD test. Most straightforward cases reach a conclusion over two to four insured visits. Details in the diagnosis guide and testing guide.
Treatment beyond stimulants
Japanese practice often starts adults on a non-stimulant. Atomoxetine builds over several weeks and suits people who want steady all-day coverage; early nausea usually settles, especially taken after food. Guanfacine began life as a blood pressure medication, so drowsiness early on and blood pressure checks come with it; it can help notably with impulsivity and emotional reactivity. Alongside medication, structure-building approaches (coaching, CBT-informed skills work, workplace adjustments) pair well with insured medical care.
Frequently asked questions
This article is general information, not medical advice for your individual situation. Decisions about diagnosis and medication belong in a consultation with a doctor who knows your history.
Medically reviewed by our psychiatrist (M.D.). Updated July 29, 2026.